(Reuters) – BioMarin Pharmaceutical Inc’s once-daily injection for children with the most common type of dwarfism received clearance from the U.S. health regulator on Friday, making it the first approved therapy for achondroplasia in the country. The approval for Voxzogo, intended for children aged five and older, comes months after it became the first therapy…
CONTINUE READING
TOMS RIVER, NJ – BarterSaves is now New Jersey’s largest independently-owned Barter Exchange. In August 2021, the company acquired BarterSystems Inc. serving businesses in the Mid-Atlantic for more than 40 years. With the stroke of a pen, BarterSaves now boasts…
CONTINUE READING
